Medical - Healthcare Plans · NYSE
Current Price
$64.99
PE Ratio (TTM)
n/m
Intrinsic Value
Use the calculator below to estimate
COMPETITIVE MOAT
↑Government Contract Expertise
Centene excels in navigating complex government contracts for Medicare and Medicaid. This deep regulatory understanding and established relationships create significant barriers to entry for new competitors.
↑Scale and Network Effects
Operating across numerous states and serving millions of members provides Centene with substantial scale. This allows for cost efficiencies and a broad provider network, enhancing member value and retention.
↑Diversified Market Presence
Centene's presence in both government-sponsored and commercial health plans diversifies revenue streams. This broad market reach offers resilience against sector-specific downturns and supports consistent cash generation.
INVESTMENT RISKS
↓Execution Risk in Acquisitions
Centene has historically grown through acquisitions. Integrating new entities and realizing expected synergies can be complex and may not always achieve desired outcomes.
↓Healthcare Cost Inflation
Rising healthcare costs, including medical claims and pharmaceutical expenses, can erode profit margins if not effectively managed through pricing strategies and cost containment measures.
↓Member Retention and Churn
Maintaining member loyalty in a competitive environment is crucial. High churn rates, driven by price sensitivity or competitor offerings, can negatively impact revenue and growth.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Centene Corp. respond.
Open PE Calculator for CNCCentene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
PE Ratio (TTM)
n/m
PEG Ratio
0.02
Earnings Yield
-15.89%
ROE (TTM)
-24.0%
Revenue/Share (TTM)
$392.32
Debt/Equity
0.71x
The trailing twelve-month PE ratio of CNC reflects how much investors pay per dollar of Centene Corp.'s earnings. This metric is most useful when compared to Medical - Healthcare Plans peers and the company's own historical range.
CNC's PE of -6.2x combined with a PEG ratio of 0.02 provides a growth-adjusted perspective. A PEG below 1.0 means the P/E is low relative to the earnings growth rate. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Medical - Healthcare Plans, a DCF analysis may be more appropriate.
To value Centene Corp. using PE: (1) Compare the current PE (-6.2x) against the Medical - Healthcare Plans median to assess relative pricing, (2) check the PEG ratio (0.02) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
CNC's PEG ratio is 0.02, calculated by dividing the PE ratio (-6.2x) by the expected earnings growth rate. A PEG below 1.0 means the P/E is low relative to the expected earnings growth rate. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how CNC is priced versus Medical - Healthcare Plans peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value CNC with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-10-07. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.